|
US11111543B2
(en)
|
2005-07-29 |
2021-09-07 |
Natera, Inc. |
System and method for cleaning noisy genetic data and determining chromosome copy number
|
|
US11111544B2
(en)
|
2005-07-29 |
2021-09-07 |
Natera, Inc. |
System and method for cleaning noisy genetic data and determining chromosome copy number
|
|
US9424392B2
(en)
|
2005-11-26 |
2016-08-23 |
Natera, Inc. |
System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals
|
|
CA3207599A1
(en)
|
2010-05-18 |
2011-11-24 |
Natera, Inc. |
Methods for non-invasive prenatal ploidy calling
|
|
US11332785B2
(en)
|
2010-05-18 |
2022-05-17 |
Natera, Inc. |
Methods for non-invasive prenatal ploidy calling
|
|
US11408031B2
(en)
|
2010-05-18 |
2022-08-09 |
Natera, Inc. |
Methods for non-invasive prenatal paternity testing
|
|
US9677118B2
(en)
|
2014-04-21 |
2017-06-13 |
Natera, Inc. |
Methods for simultaneous amplification of target loci
|
|
US11332793B2
(en)
|
2010-05-18 |
2022-05-17 |
Natera, Inc. |
Methods for simultaneous amplification of target loci
|
|
US20190010543A1
(en)
|
2010-05-18 |
2019-01-10 |
Natera, Inc. |
Methods for simultaneous amplification of target loci
|
|
US12152275B2
(en)
|
2010-05-18 |
2024-11-26 |
Natera, Inc. |
Methods for non-invasive prenatal ploidy calling
|
|
US12221653B2
(en)
|
2010-05-18 |
2025-02-11 |
Natera, Inc. |
Methods for simultaneous amplification of target loci
|
|
US11939634B2
(en)
|
2010-05-18 |
2024-03-26 |
Natera, Inc. |
Methods for simultaneous amplification of target loci
|
|
US11326208B2
(en)
|
2010-05-18 |
2022-05-10 |
Natera, Inc. |
Methods for nested PCR amplification of cell-free DNA
|
|
US11322224B2
(en)
|
2010-05-18 |
2022-05-03 |
Natera, Inc. |
Methods for non-invasive prenatal ploidy calling
|
|
US11339429B2
(en)
|
2010-05-18 |
2022-05-24 |
Natera, Inc. |
Methods for non-invasive prenatal ploidy calling
|
|
US10316362B2
(en)
|
2010-05-18 |
2019-06-11 |
Natera, Inc. |
Methods for simultaneous amplification of target loci
|
|
BR112013020220B1
(pt)
|
2011-02-09 |
2020-03-17 |
Natera, Inc. |
Método para determinar o estado de ploidia de um cromossomo em um feto em gestação
|
|
DK3246416T3
(da)
|
2011-04-15 |
2024-09-02 |
Univ Johns Hopkins |
Sikkert sekventeringssystem
|
|
US20140100126A1
(en)
|
2012-08-17 |
2014-04-10 |
Natera, Inc. |
Method for Non-Invasive Prenatal Testing Using Parental Mosaicism Data
|
|
ES2886507T5
(es)
|
2012-10-29 |
2024-11-15 |
Univ Johns Hopkins |
Prueba de Papanicolaou para cánceres de ovario y de endometrio
|
|
EP3134541B1
(en)
|
2014-04-21 |
2020-08-19 |
Natera, Inc. |
Detecting copy number variations (cnv) of chromosomal segments in cancer
|
|
US20180173846A1
(en)
|
2014-06-05 |
2018-06-21 |
Natera, Inc. |
Systems and Methods for Detection of Aneuploidy
|
|
US11479812B2
(en)
|
2015-05-11 |
2022-10-25 |
Natera, Inc. |
Methods and compositions for determining ploidy
|
|
CN108026572B
(zh)
|
2015-07-23 |
2022-07-01 |
香港中文大学 |
游离dna的片段化模式的分析
|
|
WO2017027653A1
(en)
|
2015-08-11 |
2017-02-16 |
The Johns Hopkins University |
Assaying ovarian cyst fluid
|
|
CN116987777A
(zh)
|
2016-03-25 |
2023-11-03 |
凯锐思公司 |
合成核酸掺入物
|
|
RU2760913C2
(ru)
|
2016-04-15 |
2021-12-01 |
Натера, Инк. |
Способы выявления рака легкого
|
|
WO2018067517A1
(en)
|
2016-10-04 |
2018-04-12 |
Natera, Inc. |
Methods for characterizing copy number variation using proximity-litigation sequencing
|
|
GB201618485D0
(en)
|
2016-11-02 |
2016-12-14 |
Ucl Business Plc |
Method of detecting tumour recurrence
|
|
US10011870B2
(en)
|
2016-12-07 |
2018-07-03 |
Natera, Inc. |
Compositions and methods for identifying nucleic acid molecules
|
|
IL302912A
(en)
|
2016-12-22 |
2023-07-01 |
Guardant Health Inc |
Methods and systems for analyzing nucleic acid molecules
|
|
MY197535A
(en)
|
2017-01-25 |
2023-06-21 |
Univ Hong Kong Chinese |
Diagnostic applications using nucleic acid fragments
|
|
WO2019016353A1
(en)
*
|
2017-07-21 |
2019-01-24 |
F. Hoffmann-La Roche Ag |
CLASSIFICATION OF SOMATIC MUTATIONS FROM A HETEROGENEOUS SAMPLE
|
|
CN111868260B
(zh)
|
2017-08-07 |
2025-02-21 |
约翰斯霍普金斯大学 |
用于评估和治疗癌症的方法和材料
|
|
WO2019060716A1
(en)
|
2017-09-25 |
2019-03-28 |
Freenome Holdings, Inc. |
SAMPLE EXTRACTION METHODS AND SYSTEMS
|
|
US12084720B2
(en)
|
2017-12-14 |
2024-09-10 |
Natera, Inc. |
Assessing graft suitability for transplantation
|
|
EP3743518A4
(en)
*
|
2018-01-24 |
2021-09-29 |
Freenome Holdings, Inc. |
METHODS AND SYSTEMS FOR DETECTING ANOMALY IN PATTERNS OF NUCLEIC ACIDS
|
|
EP3759238A4
(en)
*
|
2018-02-27 |
2021-11-24 |
Cornell University |
SYSTEMS AND METHODS FOR DETECTING RESIDUAL DISEASES
|
|
JP2021514663A
(ja)
*
|
2018-03-08 |
2021-06-17 |
セント・ジョーンズ・ユニバーシティＳｔ． Ｊｏｈｎｓ Ｕｎｉｖｅｒｓｉｔｙ |
循環性血清無細胞ｄｎａバイオマーカー及び方法
|
|
US20190287649A1
(en)
*
|
2018-03-13 |
2019-09-19 |
Grail, Inc. |
Method and system for selecting, managing, and analyzing data of high dimensionality
|
|
US12087406B2
(en)
|
2018-03-15 |
2024-09-10 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods using chromatin-related nucleic acid signals for performing clinical actions
|
|
EP3776555A2
(en)
*
|
2018-04-13 |
2021-02-17 |
Grail, Inc. |
Multi-assay prediction model for cancer detection
|
|
JP7455757B2
(ja)
*
|
2018-04-13 |
2024-03-26 |
フリーノーム・ホールディングス・インコーポレイテッド |
生体試料の多検体アッセイのための機械学習実装
|
|
US12024738B2
(en)
|
2018-04-14 |
2024-07-02 |
Natera, Inc. |
Methods for cancer detection and monitoring
|
|
US11482303B2
(en)
|
2018-06-01 |
2022-10-25 |
Grail, Llc |
Convolutional neural network systems and methods for data classification
|
|
WO2020006369A1
(en)
*
|
2018-06-29 |
2020-01-02 |
Guardant Health, Inc. |
Methods and systems for analysis of ctcf binding regions in cell-free dna
|
|
US12234509B2
(en)
|
2018-07-03 |
2025-02-25 |
Natera, Inc. |
Methods for detection of donor-derived cell-free DNA
|
|
WO2020096691A2
(en)
*
|
2018-09-04 |
2020-05-14 |
Guardant Health, Inc. |
Methods and systems for detecting allelic imbalance in cell-free nucleic acid samples
|
|
AU2019356497B2
(en)
*
|
2018-10-08 |
2025-06-26 |
Freenome Holdings, Inc. |
Transcription factor profiling
|
|
GB201818159D0
(en)
*
|
2018-11-07 |
2018-12-19 |
Cancer Research Tech Ltd |
Enhanced detection of target dna by fragment size analysis
|
|
WO2020106987A1
(en)
*
|
2018-11-21 |
2020-05-28 |
Karius, Inc. |
Detection and prediction of infectious disease
|
|
CA3118990A1
(en)
|
2018-11-21 |
2020-05-28 |
Karius, Inc. |
Direct-to-library methods, systems, and compositions
|
|
US10468141B1
(en)
*
|
2018-11-28 |
2019-11-05 |
Asia Genomics Pte. Ltd. |
Ancestry-specific genetic risk scores
|
|
US11581062B2
(en)
|
2018-12-10 |
2023-02-14 |
Grail, Llc |
Systems and methods for classifying patients with respect to multiple cancer classes
|
|
ES2968457T3
(es)
*
|
2018-12-19 |
2024-05-09 |
Univ Hong Kong Chinese |
Características de los extremos del ADN extracelular circulante
|
|
EP3899049A1
(en)
*
|
2018-12-21 |
2021-10-27 |
F. Hoffmann-La Roche AG |
Identification of global sequence features in whole genome sequence data from circulating nucelic acid
|
|
WO2020132499A2
(en)
*
|
2018-12-21 |
2020-06-25 |
Grail, Inc. |
Systems and methods for using fragment lengths as a predictor of cancer
|
|
WO2020150258A1
(en)
*
|
2019-01-15 |
2020-07-23 |
Luminist, Inc. |
Methods and systems for detecting liver disease
|
|
EP4632078A2
(en)
*
|
2019-01-24 |
2025-10-15 |
Illumina, Inc. |
Methods and systems for monitoring organ health and disease
|
|
EP3918089B1
(en)
|
2019-01-31 |
2025-01-15 |
Guardant Health, Inc. |
Method for isolating and sequencing cell-free dna
|
|
US11475978B2
(en)
|
2019-02-12 |
2022-10-18 |
Tempus Labs, Inc. |
Detection of human leukocyte antigen loss of heterozygosity
|
|
WO2020168016A1
(en)
|
2019-02-12 |
2020-08-20 |
Tempus Labs, Inc. |
Detection of human leukocyte antigen loss of heterozygosity
|
|
WO2020176659A1
(en)
*
|
2019-02-27 |
2020-09-03 |
Guardant Health, Inc. |
Methods and systems for determining the cellular origin of cell-free dna
|
|
EP3956466A1
(en)
*
|
2019-04-15 |
2022-02-23 |
Natera, Inc. |
Improved liquid biopsy using size selection
|
|
US11869661B2
(en)
|
2019-05-22 |
2024-01-09 |
Grail, Llc |
Systems and methods for determining whether a subject has a cancer condition using transfer learning
|
|
EP3976822A1
(en)
|
2019-05-31 |
2022-04-06 |
Guardant Health, Inc. |
Methods and systems for improving patient monitoring after surgery
|
|
WO2020247263A1
(en)
|
2019-06-06 |
2020-12-10 |
Natera, Inc. |
Methods for detecting immune cell dna and monitoring immune system
|
|
US20220259647A1
(en)
*
|
2019-07-09 |
2022-08-18 |
The Translational Genomics Research Institute |
METHODS OF DETECTING DISEASE AND TREATMENT RESPONSE IN cfDNA
|
|
US20220301654A1
(en)
*
|
2019-08-28 |
2022-09-22 |
Grail, Llc |
Systems and methods for predicting and monitoring treatment response from cell-free nucleic acids
|
|
CN110706749B
(zh)
*
|
2019-09-10 |
2022-06-10 |
至本医疗科技（上海）有限公司 |
一种基于组织器官分化层次关系的癌症类型预测系统和方法
|
|
WO2021067484A1
(en)
|
2019-09-30 |
2021-04-08 |
Guardant Health, Inc. |
Compositions and methods for analyzing cell-free dna in methylation partitioning assays
|
|
WO2021072275A1
(en)
*
|
2019-10-11 |
2021-04-15 |
Guardant Health, Inc. |
Use of cell free bacterial nucleic acids for detection of cancer
|
|
ES3031713T3
(en)
|
2019-11-26 |
2025-07-10 |
Guardant Health Inc |
Methods, compositions and systems for improving the binding of methylated polynucleotides
|
|
EP4068291A4
(en)
*
|
2019-11-29 |
2023-12-20 |
GC Genome Corporation |
METHOD FOR DETECTING CHROMOSOMAL ANOMALIES USING ARTIFICIAL INTELLIGENCE
|
|
WO2021127208A1
(en)
*
|
2019-12-20 |
2021-06-24 |
Accuragen Holdings Limited |
Methods and systems for disease detection
|
|
WO2021130356A1
(en)
*
|
2019-12-24 |
2021-07-01 |
Vib Vzw |
Disease detection in liquid biopsies
|
|
CN115516108A
(zh)
|
2020-02-14 |
2022-12-23 |
约翰斯霍普金斯大学 |
评估核酸的方法和材料
|
|
US20210285042A1
(en)
*
|
2020-02-28 |
2021-09-16 |
Grail, Inc. |
Systems and methods for calling variants using methylation sequencing data
|
|
WO2021222828A1
(en)
|
2020-04-30 |
2021-11-04 |
Guardant Health, Inc. |
Methods for sequence determination using partitioned nucleic acids
|
|
AU2021276524A1
(en)
*
|
2020-05-22 |
2023-01-05 |
Aqtual, Inc. |
Methods for characterizing cell-free nucleic acid fragments
|
|
WO2023282916A1
(en)
|
2021-07-09 |
2023-01-12 |
Guardant Health, Inc. |
Methods of detecting genomic rearrangements using cell free nucleic acids
|
|
EP4179111B1
(en)
|
2020-07-10 |
2024-04-03 |
Guardant Health, Inc. |
Methods of detecting genomic rearrangements using cell free nucleic acids
|
|
EP4585697A3
(en)
|
2020-07-30 |
2025-08-06 |
Guardant Health, Inc. |
Methods for isolating cell-free dna
|
|
JP2023540221A
(ja)
|
2020-08-25 |
2023-09-22 |
ガーダント ヘルス， インコーポレイテッド |
バリアントの起源を予測するための方法およびシステム
|
|
WO2022061080A1
(en)
*
|
2020-09-17 |
2022-03-24 |
The Regents Of The University Of Colorado, A Body Corporate |
Signatures in cell-free dna to detect disease, track treatment response, and inform treatment decisions
|
|
US20220162670A1
(en)
|
2020-09-30 |
2022-05-26 |
Guardant Health, Inc. |
Methods and systems to improve the signal to noise ratio of dna methylation partitioning assays
|
|
CA3195797A1
(en)
|
2020-10-23 |
2022-04-28 |
Andrew Kennedy |
Compositions and methods for analyzing dna using partitioning and base conversion
|
|
CA3199829A1
(en)
|
2020-11-30 |
2022-06-02 |
Guardant Health, Inc. |
Compositions and methods for enriching methylated polynucleotides
|
|
CN114634982A
(zh)
*
|
2020-12-15 |
2022-06-17 |
广州市基准医疗有限责任公司 |
一种检测多核苷酸变异的方法
|
|
EP4015650A1
(en)
*
|
2020-12-18 |
2022-06-22 |
Nipd Genetics Biotech Limited |
Methods for classifying a sample into clinically relevant categories
|
|
WO2022140629A1
(en)
|
2020-12-23 |
2022-06-30 |
Guardant Health, Inc. |
Methods and systems for analyzing methylated polynucleotides
|
|
EP4291679A1
(en)
|
2021-02-12 |
2023-12-20 |
Guardant Health, Inc. |
Methods and compositions for detecting nucleic acid variants
|
|
WO2022204730A1
(en)
|
2021-03-25 |
2022-09-29 |
Guardant Health, Inc. |
Methods and compositions for quantifying immune cell dna
|
|
WO2022248844A1
(en)
*
|
2021-05-24 |
2022-12-01 |
University Of Essex Enterprises Limited |
Method and system for identifying genomic regions with condition sensitive occupancy/positioning of nucleosomes and/or chromatin
|
|
KR20220160805A
(ko)
*
|
2021-05-28 |
2022-12-06 |
한국과학기술원 |
조직 특이적 조절지역의 무세포 dna 분포를 이용한 인공지능 기반 암 조기진단 방법
|
|
CN113838533B
(zh)
*
|
2021-08-17 |
2024-03-12 |
福建和瑞基因科技有限公司 |
一种癌症检测模型及其构建方法和试剂盒
|
|
WO2023091517A2
(en)
*
|
2021-11-17 |
2023-05-25 |
The Board Of Trustees Of The Leland Stanford Junior University |
Systems and methods for gene expression and tissue of origin inference from cell-free dna
|
|
KR102884871B1
(ko)
*
|
2022-01-26 |
2025-11-11 |
권창혁 |
암 판별 장치 및 암 판별 방법
|
|
JP2025513786A
(ja)
|
2022-04-07 |
2025-04-30 |
ガーダント ヘルス， インコーポレイテッド |
無細胞核酸分子のメチル化状態に基づいた腫瘍の存在の検出
|
|
US20250313898A1
(en)
*
|
2022-06-02 |
2025-10-09 |
The Board Of Trustees Of The Leland Stanford Junior University |
Single molecule sequencing and methylation profiling of cell-free dna
|
|
EP4547857A1
(en)
|
2022-06-30 |
2025-05-07 |
Guardant Health, Inc. |
Enrichment of aberrantly methylated dna
|
|
US20240043935A1
(en)
*
|
2022-07-29 |
2024-02-08 |
Centre For Novostics Limited |
Epigenetics analysis of cell-free dna
|
|
WO2024073508A2
(en)
|
2022-09-27 |
2024-04-04 |
Guardant Health, Inc. |
Methods and compositions for quantifying immune cell dna
|
|
CN115295074B
(zh)
*
|
2022-10-08 |
2022-12-16 |
南京世和基因生物技术股份有限公司 |
基因标志物在恶性肺结节筛查中的应用、筛查模型的构建方法和检测装置
|
|
EP4638782A2
(en)
|
2022-12-22 |
2025-10-29 |
Guardant Health, Inc. |
Integrated targeted and whole genome somatic and dna methylation sequencing workflows
|
|
WO2024137880A2
(en)
|
2022-12-22 |
2024-06-27 |
Guardant Health, Inc. |
Methods involving methylation preserving amplification with error correction
|
|
WO2024233502A1
(en)
|
2023-05-05 |
2024-11-14 |
Guardant Health, Inc. |
Cell-free dna blood-based test for cancer screening
|
|
WO2025019370A1
(en)
*
|
2023-07-14 |
2025-01-23 |
Natera, Inc. |
Methods for assaying circulating tumor dna
|
|
WO2025029475A1
(en)
|
2023-07-28 |
2025-02-06 |
Guardant Health, Inc. |
Methods to enrich nucleotide variants by negative selection
|
|
WO2025038399A1
(en)
|
2023-08-11 |
2025-02-20 |
Guardant Health, Inc. |
Methylated enrichment methods for single-molecule genetic and epigenetic sequencing
|
|
CN117230165A
(zh)
*
|
2023-09-01 |
2023-12-15 |
深圳湾实验室 |
一种无创产前检测胎儿染色体拷贝数异常的优化方法
|
|
WO2025064706A1
(en)
|
2023-09-19 |
2025-03-27 |
Guardant Health, Inc. |
Detecting the presence of a tumor based on methylation status of cell-free nucleic acid molecules
|
|
WO2025076452A1
(en)
|
2023-10-06 |
2025-04-10 |
Guardant Health, Inc. |
Detecting tumor-related information based on methylation status of cell-free nucleic acid molecules
|
|
WO2025207817A1
(en)
|
2024-03-26 |
2025-10-02 |
Guardant Health, Inc. |
Method of determining the likelihood of a disease by combining biomarkers and imaging
|
|
WO2025208044A1
(en)
|
2024-03-28 |
2025-10-02 |
Guardant Health, Inc. |
Methods for cancer detection using molecular patterns
|
|
WO2025205006A1
(ja)
*
|
2024-03-29 |
2025-10-02 |
ソニーグループ株式会社 |
分析方法、クロマチン状態を分類する方法、がん検査方法、分析システム、がん又は微小残存病変の検査システムおよび分析キット
|
|
WO2025235889A1
(en)
|
2024-05-10 |
2025-11-13 |
Guardant Health, Inc. |
Methods involving multiplexed pooled pcr
|
|
WO2025250544A1
(en)
|
2024-05-31 |
2025-12-04 |
Guardant Health, Inc. |
Methods for analyzing chromatin architecture in tissue to boost detection of cancer associated signals in cell-free dna
|
|
CN120334449B
(zh)
*
|
2025-06-20 |
2025-09-05 |
陕西右任故里茯砖茶股份有限公司 |
基于液相色谱的茯砖茶中金花菌发酵检测方法
|